Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing cancer stem cell spheroids

A technology of cancer stem cells and cancer cells, which is applied in the field of drugs for the treatment of cancer cell resistance, and can solve problems such as insufficient inclusion of cancer stem cells

Pending Publication Date: 2020-09-04
KOREA ADVANCED INST OF SCI & TECH
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, even spheroids produced by this method cannot adequately contain cancer stem cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing cancer stem cell spheroids
  • Method for preparing cancer stem cell spheroids
  • Method for preparing cancer stem cell spheroids

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0101] Reference Example 1: Analysis of Heterogeneous Tumor Formation

[0102] Female BALB / c nude mice (6 weeks) were obtained from Orient Bio Inc. and stored under sterile conditions in the animal laboratory of the Korea Advanced Institute of Science and Technology middle. Mice were randomly assigned to randomized experimental groups. All operations were performed under isoflurane anesthesia, and for ethical procedures and scientific management, all animal-related procedures were reviewed and approved by the Korea Advanced Institute of Science and Technology, Institutional Animal Care and Use Committee (KAIST-IACUC) (approval number: KA2014- twenty one).

[0103] In addition, in order to prepare a heterogeneous model of human ovarian cancer, different series of concentrations (10 6 to 10 2 2D cultured control SKOV3 cells) or SKOV3-ssiCSCs isolated from their corresponding spheroids were mixed with 50% Matrigel (Corning), and then subcutaneously injected into 6-week-old fe...

example 3

[0106] Reference Example 3: Histological Analysis and Immunohistochemistry

[0107] Liver biopsy samples obtained from BALB / c nude mice inoculated with 2D control or SKOV3-ssiCSC cancer cells were fixed with 10% formalin, dehydrated and embedded in paraffin, cut into 5 μm thick samples, and placed in on a glass slide. Samples were deparaffinized and stained with hematoxylin % eosin (H&E) for histological evaluation with a standard light microscope (Eclipse 80i, Nickon).

[0108] Liver metastases were confirmed by immunohistochemistry after paraffin embedding and fragmentation (5 μm) of the tissue. The broken liver tissue was sterilized with 10 mM sodium citrate buffer (pH 6.0) for antigen retrieval, blocked with PBS containing 5% bovine serum albumin (BSA) and 1% goat serum, and then incubated with rabbit antibody Human TNC primary antibody (20 μg / mL; cat# AB19011; Millipore) was incubated for 1 hour at room temperature (RT). After incubation, slides were washed with D-PBS, i...

example 4

[0109] Reference Example 4: Western Blot Analysis

[0110] 2D control SKOV3 cells and SKOV3-ssiCSC spheroids were lysed with RIPA lysis buffer (ThermoFisher Scientific) containing protease inhibition cocktail for 30 min on ice. Lysate protein was quantified using the Bradford protein assay kit (Bio-Rad), and equal amounts of protein (50 μg) were separated by electrophoresis using a Bolt 4-12% Bis-Tris Plus polyacrylamide gel (ThermoFisher Scientific). Gels were dry-blotted onto PVDF (polyvinylidene difluoride) membranes using the iBlot2 transfer system (ThermoFisher Scientific) according to the manufacturer's instructions.

[0111] PVDF membrane was passed through the primary antibody of rabbit anti-phospho-β-catenin (1:1000, catalog number 9561; Cell Signaling Technology), mouse anti-β-catenin antibody (1:1000, catalog number 13-8400; Invitrogen) and rabbit anti- Western blots were incubated with GAPDH antibody (1:1000, cat. #25778; Santa Cruz Biotechnology), which was then ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
water contact angleaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a method or a kit for preparing cancer stem cell spheroids and a method for screening a cancer cell resistance treating drug by means of the prepared cancer stem cellspheroids. Cancer stem cell spheroids can be prepared in a simple manner, and the prepared cancer stem cell spheroids can effectively be utilized for screening a cancer cell resistance treating drug.

Description

technical field [0001] The present invention relates to a method or kit for producing cancer stem cell spheroids. In addition, the present invention relates to a method for screening a drug for treating cancer cell resistance using the cancer stem cell spheroid prepared by the method or the kit. Background technique [0002] Cancer stem cells (CSCs or tumor-initiating cells: TICs) have many characteristics similar to normal stem cells, such as self-regeneration ability, endogenous drug resistance, and differentiation. Since stem cell-like cancer cells have been identified in acute myeloid leukemia, evidence has mounted that small numbers of cancer stem cells reside in tumor aggregates that are primarily responsible for tumor relapse and drug resistance. Therefore, cancer stem cells have attracted considerable attention in the fields of cancer research and drug resistance. [0003] Cancer stem cells are typically isolated from patient-derived tumor tissue based on cancer st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/095G01N33/50
CPCA61K35/13G01N33/5011C12N5/0695C12N2513/00C12N2533/50C12N2533/30G01N33/5017C12N2500/30C12N5/0018C12N2500/50C12N2501/998
Inventor 全相镕崔敏硕任城甲李大烨刘承政磪允祯
Owner KOREA ADVANCED INST OF SCI & TECH
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More